Apogee Therapeutics Inc (APGE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Apogee Therapeutics Inc   (NASDAQ: APGE)


Apogee Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Apogee Therapeutics Inc's ROI in the second quarter of 2026?
Apogee Therapeutics Inc recorded a cumulative net loss of $-294 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -14.72%.

Within the Healthcare sector 274 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3055 to 3244.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 44.93 % 15.95 % -7.93 % -3.17 % 27.7 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2,493 2,516 1,813 1,178 1,246
Return On Investment (TTM) -14.72 % -16.26 % -18.3 % -19.44 % -17.22 %
APGE's Overall Ranking # 3244 # 3055 # 2678 # 3113 # 3189
Seq. Investment Change TTM 18.47 % 20.78 % 7.1 % -5.43 % -5.22 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -294 -275 -256 -254 -238

APGE Company Profile >> Back to APGE Roi Comparisons >> See Annual APGE Return On Investment



Return On Investment APGE's Ranking
Within: No.
Industry # 30
Sector # 275
Overall # 3244

Return On Investment Statistics
High Average Low
-12 %
-21.26 %
-42.87 %
(Dec 31 2024)   (Jun 30 2024)







Financial Statements
Apogee Therapeutics Inc's II. Quarter Investments $ 2,493 Millions APGE's Balance sheet
Apogee Therapeutics Inc's II. Quarter Income $ -86 Millions Quarterly APGE's Income Statement
APGE's Income by Division See APGE's Income by Division


APGE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023

Total Investments in Millions 909 725 760 0 0
Y / Y Investment Growth 25.34 % -4.6 % - - -
Net Income in Millions -256 -182 -84 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -28.14 % -25.11 % -11.04 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
APGE's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for APGE's Competitors
Subscribers only: Roi for Apogee Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for APGE's Customers

Other Ratios
APGE's Roa APGE's Inventory Turnover Ratio APGE's Growth Rates APGE's Dividend Statistics
APGE's Profitability Ratios APGE's Asset Turnover Ratio APGE's Dividend Growth
APGE's Roe APGE's Valuation Ratios APGE's Financial Strength Ratios APGE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:42:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.